Australia’s first national biotech incubator announces $17 M funding

Australia’s national biotechnology incubator CUREator has announced over $17 million in funding for 23 projects ac...

July 21, 2022 | Thursday | News
Oncoshot partners with Australian Genomic Cancer Medicine Centre

Singapore-based firm Oncoshot has entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medic...

July 22, 2022 | Friday | News
Australia provisionally approves Moderna's COVID-19 vaccine for kids below 6 yrs

US-based Moderna has announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional regi...

July 19, 2022 | Tuesday | News
Discovery by Australia boosts hopes of preventing Type I diabetes

Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could...

July 18, 2022 | Monday | News
Australia clears Vivos technology to treat obstructive sleep apnea

Vivos Therapeutics has received multiple Class I clearances by the Therapeutic Goods Administration (TGA) of Australia, ...

July 15, 2022 | Friday | News
Australia launches Cancer Hub

The Australian Government has launched the Cancer Hub – a national one-stop digital hub that will change the ...

July 14, 2022 | Thursday | News
Reece Pharma appoints industry research leader to head translational biz

Australia's Recce Pharmaceuticals, developing a New Class of Synthetic Anti-infectives, has announced the appointm...

July 13, 2022 | Wednesday | News
Australia's Telix Pharma appoints new CEO for US operations

Australian firm Telix Pharmaceuticals has announced that Kevin Richardson, a senior global executive with a career focus...

July 12, 2022 | Tuesday | News
AusBiotech expands investment attraction portfolio

AusBiotech has announced an expanded investment attraction, commenced in line with a new investment attraction strategy....

July 12, 2022 | Tuesday | News
Australia uses machine learning to provide early warning for emerging COVID-19 variants

Researchers at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national scie...

July 11, 2022 | Monday | News
Australia uncovers driving forces of Alzheimer’s disease

Alzheimer’s disease, the most common form of dementia, currently has no cure or effective therapy, in part due to ...

July 8, 2022 | Friday | News
harrison.ai & Sonic Healthcare join forces to bring AI to pathology in Australia

Australia-based harrison.ai, a clinically led healthcare AI platform and Sonic Healthcare, the global medical diagn...

July 7, 2022 | Thursday | News
Australian scientists provide insights into colon cancer prevention

Scientists in Australia have isolated five strains of gut bacteria that could pave the way for new inflammatory bowel di...

July 6, 2022 | Wednesday | News
ResApp Health receives US FDA clearance for at-home sleep test

Australian firm ResApp Health, a leading digital health company developing smartphone applications for the diagnosis and...

July 6, 2022 | Wednesday | News
“ATH434 has the potential to address the underlying pathology of Multiple System Atrophy”

In conversation with BioSpectrum Asia, Dr David Stamler, Chief Executive Officer, Alterity Therapeutics reveals more abo...

July 5, 2022 | Tuesday | Opinion
Australia invests $220 M to support aged care facilities

The Australian Government is investing $106 million to provide face-to-face support for older First Nations people and $...

July 5, 2022 | Tuesday | News
Australia explores deadly spider venom treatment for heart attacks with $23M funding

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer ...

July 4, 2022 | Monday | News
Australia's EnGeneIC brings 2nd-Gen COVID-19 vaccine against all variants

Australian biopharma company EnGeneIC is developing the world’s first COVID-19 vaccine which can offer immunity ag...

June 29, 2022 | Wednesday | News